MXPA05010704A - Composiciones farmaceuticas que comprenden un inmunomodulador de macrolido. - Google Patents
Composiciones farmaceuticas que comprenden un inmunomodulador de macrolido.Info
- Publication number
- MXPA05010704A MXPA05010704A MXPA05010704A MXPA05010704A MXPA05010704A MX PA05010704 A MXPA05010704 A MX PA05010704A MX PA05010704 A MXPA05010704 A MX PA05010704A MX PA05010704 A MXPA05010704 A MX PA05010704A MX PA05010704 A MXPA05010704 A MX PA05010704A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- macrolide
- immunomodulator
- ceramide
- macrolide immunomodulator
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- 229940121354 immunomodulator Drugs 0.000 title abstract 2
- 230000002584 immunomodulator Effects 0.000 title abstract 2
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 abstract 1
- 206010012438 Dermatitis atopic Diseases 0.000 abstract 1
- 206010012442 Dermatitis contact Diseases 0.000 abstract 1
- 206010013786 Dry skin Diseases 0.000 abstract 1
- 206010014190 Eczema asteatotic Diseases 0.000 abstract 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 abstract 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 abstract 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 abstract 1
- 206010048222 Xerosis Diseases 0.000 abstract 1
- 201000008937 atopic dermatitis Diseases 0.000 abstract 1
- 229940106189 ceramide Drugs 0.000 abstract 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 abstract 1
- -1 ceramide 3 Chemical compound 0.000 abstract 1
- 229940044176 ceramide 3 Drugs 0.000 abstract 1
- 208000010247 contact dermatitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000037336 dry skin Effects 0.000 abstract 1
- 229960003444 immunosuppressant agent Drugs 0.000 abstract 1
- 230000001861 immunosuppressant effect Effects 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 abstract 1
- 235000020778 linoleic acid Nutrition 0.000 abstract 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 abstract 1
- KASDHRXLYQOAKZ-OLHLVPFQSA-N pimecrolimus Chemical compound C/C([C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@@H](OC)C[C@@H](C)C\C(C)=C/[C@H](C(C[C@H](O)[C@H]1C)=O)CC)=C\[C@@H]1CC[C@H](Cl)[C@H](OC)C1 KASDHRXLYQOAKZ-OLHLVPFQSA-N 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307867.2A GB0307867D0 (en) | 2003-04-04 | 2003-04-04 | Pharmaceutical composition |
| PCT/EP2004/003514 WO2004087202A2 (en) | 2003-04-04 | 2004-04-02 | Pharmaceutical composition comprising a macrolide immunomodulator |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05010704A true MXPA05010704A (es) | 2005-12-12 |
Family
ID=9956230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05010704A MXPA05010704A (es) | 2003-04-04 | 2004-04-02 | Composiciones farmaceuticas que comprenden un inmunomodulador de macrolido. |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20070021377A1 (https=) |
| EP (1) | EP1638558A2 (https=) |
| JP (1) | JP2006522060A (https=) |
| CN (1) | CN1764455A (https=) |
| BR (1) | BRPI0409169A (https=) |
| CA (1) | CA2519958A1 (https=) |
| GB (1) | GB0307867D0 (https=) |
| IS (1) | IS8103A (https=) |
| MX (1) | MXPA05010704A (https=) |
| NO (1) | NO20055170L (https=) |
| RS (1) | RS20050723A (https=) |
| WO (1) | WO2004087202A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885491B1 (fr) * | 2005-05-16 | 2020-03-06 | Nutricos Technologies | Traitement de la secheresse keratinique par des glycerides |
| DE102007052380A1 (de) * | 2007-10-31 | 2009-05-07 | Bitop Ag | Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten |
| CN120754078A (zh) * | 2024-07-30 | 2025-10-10 | 中山大学 | 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| FR2710527B1 (fr) * | 1993-09-30 | 1995-12-08 | Roussel Uclaf | Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation. |
| JPH08133979A (ja) * | 1994-09-16 | 1996-05-28 | Sando Yakuhin Kk | 局所適用薬剤組成物 |
| ATE299017T1 (de) * | 1994-10-26 | 2005-07-15 | Novartis Pharma Gmbh | Arzneimittel |
| DE19544507B4 (de) * | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin enthaltende Präparate |
| GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| DK1064942T3 (da) * | 1998-03-26 | 2004-11-01 | Fujisawa Pharmaceutical Co | Sustained release-fremstilling af et makrolid |
| GB0003932D0 (en) * | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
| GB0125443D0 (en) * | 2001-10-23 | 2001-12-12 | Novartis Ag | Organic Compounds |
| GB0200429D0 (en) * | 2002-01-09 | 2002-02-27 | Novartis Ag | Organic compounds |
-
2003
- 2003-04-04 GB GBGB0307867.2A patent/GB0307867D0/en not_active Ceased
-
2004
- 2004-04-02 JP JP2006504967A patent/JP2006522060A/ja active Pending
- 2004-04-02 BR BRPI0409169-8A patent/BRPI0409169A/pt not_active IP Right Cessation
- 2004-04-02 WO PCT/EP2004/003514 patent/WO2004087202A2/en not_active Ceased
- 2004-04-02 EP EP04725363A patent/EP1638558A2/en not_active Withdrawn
- 2004-04-02 CN CNA2004800080903A patent/CN1764455A/zh active Pending
- 2004-04-02 MX MXPA05010704A patent/MXPA05010704A/es unknown
- 2004-04-02 US US10/550,356 patent/US20070021377A1/en not_active Abandoned
- 2004-04-02 CA CA002519958A patent/CA2519958A1/en not_active Abandoned
- 2004-04-02 RS YUP-2005/0723A patent/RS20050723A/sr unknown
-
2005
- 2005-10-31 IS IS8103A patent/IS8103A/is unknown
- 2005-11-03 NO NO20055170A patent/NO20055170L/no not_active Application Discontinuation
-
2007
- 2007-10-10 US US11/973,849 patent/US20080132534A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0409169A (pt) | 2006-04-11 |
| CA2519958A1 (en) | 2004-10-14 |
| AU2004226822A1 (en) | 2004-10-14 |
| CN1764455A (zh) | 2006-04-26 |
| NO20055170D0 (no) | 2005-11-03 |
| GB0307867D0 (en) | 2003-05-14 |
| WO2004087202A2 (en) | 2004-10-14 |
| RS20050723A (sr) | 2007-11-15 |
| JP2006522060A (ja) | 2006-09-28 |
| NO20055170L (no) | 2006-01-04 |
| EP1638558A2 (en) | 2006-03-29 |
| WO2004087202A3 (en) | 2005-02-03 |
| US20070021377A1 (en) | 2007-01-25 |
| US20080132534A1 (en) | 2008-06-05 |
| IS8103A (is) | 2005-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05010708A (es) | Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel. | |
| EP1676512A3 (en) | Skin treatment articles and methods | |
| EP2335722A3 (en) | Use of gelsolin to treat infections | |
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
| MY147247A (en) | Organic compounds and their uses | |
| MY147489A (en) | Methods for the treatment of muscle loss | |
| PL1620113T3 (pl) | Formulacja iwermektyny do stosowania miejscowego do leczenia schorzeń dermatologicznych | |
| WO2009050580A8 (fr) | Composition destinee a la regulation du metabolism des lipides | |
| PT1620113E (pt) | Formulação tópica de ivermectina para o tratamento de condições dermatológicas | |
| WO2007112453A3 (en) | Methods amd compositions for treating conditions | |
| DK1255564T3 (da) | Farmaceutisk sammensætning omfattende squalenepoxydasehæmmer og makrolid immunomodulator | |
| IL172773A (en) | Formulations for the treatment of arthritis conditions | |
| WO2006120681A3 (en) | Compositions and methods for skin care | |
| WO2008148966A3 (fr) | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations | |
| WO2004034958A3 (en) | Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin | |
| MXPA05010704A (es) | Composiciones farmaceuticas que comprenden un inmunomodulador de macrolido. | |
| TWI372047B (en) | Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same | |
| WO2002087533A8 (de) | Verwendung von klee-extrakt zur prophylaxe gegen und behandlung von degenerativen hauterscheinungen | |
| WO2008078050A3 (fr) | Utilisation d'au moins un acide gras mono-insature pour le traitement des peaux, muqueuses ou semi-muqueuses et cuirs chevelus fragiles | |
| MXPA05010702A (es) | Combinacion de un inmunomodulador de celula t de macrolido y un calciferol para el tratamiento de enfermedades de la piel o de enfermedad inflamatoria del intestino. | |
| WO2004112808A3 (fr) | Utilisation therapeutique de lipides extraits de nacre | |
| EP2103310A8 (en) | Method for the prevention or treatment of ischemia reperfusion injury. | |
| WO2009019433A3 (en) | Fertilisation protein | |
| WO2006015183A3 (en) | Pharmaceutical compositions for treating disorders of the skin |